A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

Clinical trial NCT07612189 · RECRUITING

Trial details

NCT number: NCT07612189
Sponsor: NEOK Bio, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced (Unresectable) or Metastatic Solid Tumors

Start date: 2026-04-22
Primary completion: 2029-02-01
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.